Compare, Analyse IPCA Labs with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs ADCOCK INGRAM (S. Africa) - Comparison Results

IPCA LABS     Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 IPCA LABS   ADCOCK INGRAM
EQUITY SHARE DATA
    IPCA LABS
Mar-19
ADCOCK INGRAM
Jun-14
IPCA LABS/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,042326-   
Low Rs590235-   
Sales per share (Unadj.) Rs298.696.8-  
Earnings per share (Unadj.) Rs35.0-24.4-  
Cash flow per share (Unadj.) Rs49.4-20.2-  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs247.176.0-  
Shares outstanding (eoy) m126.35168.78-   
Bonus/Rights/Conversions ESOS--  
Price / Sales ratio x2.72.9 94.4%   
Avg P/E ratio x23.3-11.5 -203.1%  
P/CF ratio (eoy) x16.5-13.9 -119.1%  
Price / Book Value ratio x3.33.7 89.6%  
Dividend payout %8.60-   
Avg Mkt Cap Rs m103,10847,288 218.0%   
No. of employees `00013.44.3 313.1%   
Total wages/salary Rs m7,8742,968 265.3%   
Avg. sales/employee Rs Th2,807.03,807.0 73.7%   
Avg. wages/employee Rs Th585.8691.3 84.7%   
Avg. net profit/employee Rs Th329.0-959.3 -34.3%   
INCOME DATA
Net Sales Rs m37,73216,344 230.9%  
Other income Rs m577114 504.0%   
Total revenues Rs m38,30916,458 232.8%   
Gross profit Rs m6,901-2,832 -243.6%  
Depreciation Rs m1,824705 258.6%   
Interest Rs m189443 42.6%   
Profit before tax Rs m5,465-3,866 -141.4%   
Minority Interest Rs m0-11 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,042242 431.5%   
Profit after tax Rs m4,422-4,118 -107.4%  
Gross profit margin %18.3-17.3 -105.5%  
Effective tax rate %19.1-6.2 -305.3%   
Net profit margin %11.7-25.2 -46.5%  
BALANCE SHEET DATA
Current assets Rs m23,77811,970 198.6%   
Current liabilities Rs m10,9756,735 163.0%   
Net working cap to sales %33.932.0 105.9%  
Current ratio x2.21.8 121.9%  
Inventory Days Days104111 93.5%  
Debtors Days Days66124 53.2%  
Net fixed assets Rs m20,3686,977 291.9%   
Share capital Rs m25376 333.0%   
"Free" reserves Rs m30,9710-   
Net worth Rs m31,22412,828 243.4%   
Long term debt Rs m1,4094,508 31.2%   
Total assets Rs m45,50724,233 187.8%  
Interest coverage x30.0-7.7 -387.5%   
Debt to equity ratio x00.4 12.8%  
Sales to assets ratio x0.80.7 122.9%   
Return on assets %10.1-15.2 -66.8%  
Return on equity %14.2-32.1 -44.1%  
Return on capital %17.3-19.8 -87.5%  
Exports to sales %45.90-   
Imports to sales %16.60-   
Net fx Rs m11,0420-   
CASH FLOW
From Operations Rs m4,9231,395 352.9%  
From Investments Rs m-1,563-428 364.9%  
From Financial Activity Rs m-1,8324,091 -44.8%  
Net Cashflow Rs m1,5285,058 30.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.49 Rs / ZAR

Compare IPCA LABS With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare IPCA LABS With: GSK PHARMA  FRESENIUS KABI ONCO.  ALKEM LABORATORIES  FDC LTD.  PIRAMAL ENTERPRISES  



Today's Market

Sensex Ends 307 Points Higher; Metal and Telecom Stocks Witness Buying(Closing)

Indian share markets traded on a positive note throughout the day and ended higher, tracking positive global sentiments.

Related Views On News

IPCA LABS Announces Quarterly Results (3QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 22.8% YoY). Sales on the other hand came in at Rs 11 bn (up 20.2% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (2QFY20); Net Profit Up 63.7% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 63.7% YoY). Sales on the other hand came in at Rs 12 bn (up 21.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

More Views on News

Most Popular

6 Charts Showing the State of Indian Financial Markets in 2020 (Sector Info)

May 26, 2020

Six charts showing how Indian financial markets have performed in 2020 so far...

Why We Picked This Smallcap Stock for a Post Coronavirus World (Profit Hunter)

May 28, 2020

Covid-19 has made it a survival of the fittest race for many companies. The ones that can adapt will thrive in a post crisis world.

The Best Safe Investment for Senior Citizens (Fast Profits Daily)

Jun 4, 2020

With Interest rates near record lows, there is a safe investment which still pays a decent interest.

Who Will Be Crowned the 'Multibagger Blue Chip' of the Decade? (Profit Hunter)

May 25, 2020

Will the mutlibagger blue chips of the past decade continue to rule the bourses?

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

How to Trade the Coronavirus Crash - Download this FREE Report Now
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

IPCA LABS SHARE PRICE


Jun 5, 2020 (Close)

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON IPCA LABS

IPCA LABS 8-QTR ANALYSIS

COMPARE IPCA LABS WITH

OTHER USEFUL LINKS

MARKET STATS